Q4 2019 USANA Health Sciences Earnings Conference Call

February 5, 2020 - 11:00 am ET


Third quarter net sales of $260.6 million


Third quarter diluted earnings per share $1.09

12.7% - 12.9%

An estimated operating margin of between 12.7% and 12.9%

For complete information regarding our financials, see our periodic filings

Latest Annual Filing

Fiscal Year Ended Dec 29, 2018

Annual report pursuant to Section 13 and 15(d)


Latest Annual Meeting

May 2, 2018 • 12:00pm EST

USANA Health Sciences 2018 Annual Meeting of Shareholders

Enabling Everyone Across the Globe to Live Well

USANA develops and manufactures high-quality nutritional supplements, healthy foods and personal care products that are sold directly to Associates and Preferred Customers around the globe.


Percent of Product Sales 2017

Top-Selling Products Percentage Of Total Product Sales 2017

Net Sales by Region 2017

Growth Strategy

We call upon our five strategic principles to enhance our business, increase the number of Associates and Preferred Customers who use our products throughout the world and, thereby, further our company vision.

View Strategy

Strategic Principles

By executing both worldwide and region-specific initiatives, we can increase our overall active Customer counts.

This initiative focuses on personalizing and improving our overall business, as well as our customers’ experience with USANA.

Our research and development focus has been and will continue to be centered on personalization and innovation

Our strategy is focused on generating customer growth in each market.

We believe that significant growth opportunities continue to exist in markets where we currently conduct business and in new international markets.